Directional Atherectomy and Drug-Coated Balloon Use in a PAD Safety-Net Population: A Retrospective Review
Abstract
BACKGROUND: Peripheral artery disease (PAD) is associated with high morbidity and mortality, particularly once patients develop critical limb threatening ischemia (CLTI). Minorities and vulnerable populations often present with CLTI and experience worse outcomes. The use of directional atherectomy (DA) and drug-coated balloon (DCB) during lower-extremity revascularization (LER) has not been previously described in a safety-net population.
OBJECTIVE: To review demographic and clinical characteristics, and short- intermediate term outcomes of patients presenting to a safety-net hospital with PAD treated with DA and DCB during LER.
METHODS: In this retrospective, observational cohort study, chart review was performed of all patients who underwent DA and DCB during LER for PAD from April 2016 to January 2020 in a safety-net hospital. […]
Reprinted with permission from J INVASIVE CARDIOL 2023;35(4):E205-E216. doi: 10.25270/jic/22.00382
Click here to continue reading the original publication in the Journal of Invasive Cardiology or click the red PDF icon above to continue reading the article in Cath Lab Digest.
Find More:
Peripheral Artery Disease Topic Center
Cardiovascular Ambulatory Surgery Centers (ASCs) Topic Center
The Latest Clinical & Industry News
Grand Rounds With Morton Kern, MD
Podcasts: Cath Lab Conversations
Go to Cath Lab Digest's current issue page
